Crosspoint Real Estate, international partner of Savills in Romania, has assisted the pharmaceutical company Biofarm in a significant transaction. The deal, worth approximately EUR 5 million, involved the sale of a strategic property in the city centre of Bucharest to Iancu de Hunedoara Residence SRL.
The transaction was exclusively brokered by Crosspoint Real Estate, with the Land Development department advising the seller and the Residential department representing the buyer.
The transacted land plot is located in a prime area of the capital, on Bulevardul Iancu de Hunedoara 40-42, on the site of the former Industria Chimico-pharmaceutica No. 2 factory.
“We are pleased with every project that is successfully completed, particularly when it is carried out in collaboration with partners with whom we have a number of successful projects. The buyer is one of the clients we are constantly in touch with, always looking for new investment opportunities. This transaction also represents the security of a lasting collaboration, as we have already established the premises of an agreement for the promotion of the future residential project that will be developed here”. – said Oana Popescu, Head of Residential Crosspoint Real Estate.
This acquisition marks an important step in the development of one of Bucharest’s inner-city sites, which will feature 6,700 sqm of housing. Thanks to its privileged location, with quick access to various points of interest in the city, the future project has great potential and will actively contribute to the overall improvement of the area, providing benefits to the local community and new opportunities for the residents of Bucharest.
“We are happy to complete another benchmark transaction for the land market in Romania, at a new record price, and to further assist the buyer in developing a so far unique project in the Bucharest market. I would like to congratulate the Land department for its involvement in the delivery of a new mandate for our client, a leader in the pharmaceutical market, which through this transaction is able to release capital for investment in the expansion of its pharmaceutical production and distribution business. We delivered a result that exceeded expectations, both in terms of the value generated and the time taken to complete the transaction. Thanks also to the residential team who supported the buyer throughout the process”. – said Cătălin Gavrilă, Partner, Crosspoint Real Estate.
With this transaction, Crosspoint Real Estate underlines its continued commitment to its partners and strengthens its position as a market leader in providing the highest quality, personalised real estate solutions.
